X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1561) 1561
male (1440) 1440
index medicus (1229) 1229
prostate cancer (1052) 1052
radical prostatectomy (961) 961
urology & nephrology (826) 826
aged (814) 814
middle aged (765) 765
prostatectomy (662) 662
prostatic neoplasms - surgery (580) 580
cancer (568) 568
oncology (538) 538
surgery (525) 525
prostatic neoplasms - pathology (415) 415
care and treatment (402) 402
urology (381) 381
prostatectomy - methods (360) 360
treatment outcome (352) 352
outcomes (328) 328
men (318) 318
prostate (274) 274
retrospective studies (271) 271
prostatic neoplasms - therapy (267) 267
research (267) 267
adult (262) 262
analysis (258) 258
health aspects (252) 252
radiotherapy (248) 248
aged, 80 and over (243) 243
risk factors (242) 242
mortality (229) 229
medicine & public health (209) 209
prostate-specific antigen - blood (206) 206
diagnosis (198) 198
robotic surgery (190) 190
neoplasm staging (178) 178
risk (178) 178
usage (175) 175
female (171) 171
quality-of-life (170) 170
prostatic neoplasms - mortality (167) 167
prostatic neoplasms - diagnosis (165) 165
united states (163) 163
prostatic neoplasms - radiotherapy (160) 160
prostatectomy - adverse effects (154) 154
survival (153) 153
complications (146) 146
laparoscopy (146) 146
patients (146) 146
biopsy (143) 143
robotics (143) 143
quality of life (142) 142
prognosis (137) 137
prostatic neoplasms - epidemiology (137) 137
abridged index medicus (136) 136
carcinoma (134) 134
patient outcomes (130) 130
radiation-therapy (130) 130
impact (129) 129
prostatectomy - utilization (127) 127
management (126) 126
trends (123) 123
follow-up studies (122) 122
prostatic neoplasms (122) 122
radiation therapy (118) 118
therapy (118) 118
cohort studies (115) 115
radiology, nuclear medicine & medical imaging (115) 115
united-states (114) 114
active surveillance (113) 113
prostate - pathology (113) 113
time factors (111) 111
neoplasm grading (107) 107
prostatectomy - statistics & numerical data (106) 106
prostate-specific antigen (104) 104
prostatic neoplasms - blood (104) 104
prospective studies (102) 102
methods (101) 101
risk assessment (101) 101
follow-up (95) 95
antigen (94) 94
multivariate analysis (94) 94
prostatectomy - economics (94) 94
metastasis (93) 93
united states - epidemiology (92) 92
robots (91) 91
oncology, experimental (90) 90
hospitals (89) 89
care (88) 88
retropubic prostatectomy (88) 88
survival rate (86) 86
hematology, oncology and palliative medicine (85) 85
radiation (85) 85
biochemical recurrence (84) 84
comorbidity (81) 81
experience (79) 79
laparoscopic surgery (79) 79
nephrology (79) 79
tumors (76) 76
erectile dysfunction (75) 75
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1849) 1849
German (27) 27
French (19) 19
Spanish (11) 11
Japanese (3) 3
Danish (1) 1
Italian (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 1527-7755, 2008, Volume 26, Issue 14, pp. 2278 - 2284
...; however, outcomes remain unclear. We assessed utilization, complications, lengths of stay, and salvage therapy rates for MIRP versus open radical prostatectomy assessed whether MIRP surgeon volume is associated with better outcomes... 
ASSISTED LAPAROSCOPIC PROSTATECTOMY | MORBIDITY | ONCOLOGY | HOSPITAL STAY | INCONTINENCE | CONTINENCE | PERIOPERATIVE COMPLICATIONS | RETROPUBIC PROSTATECTOMY | EXPERIENCE | TIME TRENDS | CANCER | Prostatectomy - methods | Prostatic Neoplasms - surgery | Humans | Prostatectomy - utilization | Male | Treatment Outcome | Aged | Prostatectomy - adverse effects
Journal Article
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 04/2017, Volume 97, Issue 5, pp. 962 - 975
We compare the efficacy and toxicity among the 3 major modalities available used to treat high-risk prostate cancer (HRCaP). From 1996 to 2012, 2557 HRCaP... 
PHASE-III TRIAL | ONCOLOGY | ADENOCARCINOMA | CONSENSUS CONFERENCE | BIOCHEMICAL FAILURE | RANDOMIZED-TRIAL | INTERMEDIATE | RADIOTHERAPY | SUPPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | HORMONAL-THERAPY | NEOADJUVANT | Radiation Injuries - mortality | Humans | Middle Aged | Chemoradiotherapy - mortality | Male | Salvage Therapy - utilization | Prostatic Neoplasms - therapy | Radiotherapy, Adjuvant - mortality | Aged, 80 and over | Adult | Retrospective Studies | Ohio - epidemiology | Chemoradiotherapy - utilization | Radiotherapy, Conformal - utilization | Salvage Therapy - mortality | Brachytherapy - mortality | Gastrointestinal Diseases - mortality | Gastrointestinal Diseases - prevention & control | Survival Rate | Treatment Outcome | Prostatic Neoplasms - mortality | Disease-Free Survival | Radiation Injuries - prevention & control | Radiotherapy, Conformal - mortality | Prostatectomy - utilization | Aged | Brachytherapy - utilization | Androgen Antagonists - administration & dosage | Prostatectomy - mortality | Radiotherapy, Adjuvant - utilization | Longitudinal Studies | Continuing medical education | Care and treatment | Radioisotope brachytherapy | Surgery | Adjuvant treatment | Health aspects | Prostate cancer | Risk factors | Cancer | Mortality | Index Medicus | PROSTATE | EXTERNAL BEAM RADIATION THERAPY | NEOPLASMS | RADIATION HAZARDS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | TOXICITY | ANDROGENS | BRACHYTHERAPY
Journal Article
Journal Article
Indian Journal of Cancer, ISSN 0019-509X, 04/2017, Volume 54, Issue 2, pp. 421 - 425
BACKGROUND: The utilization and extent of pelvic lymph node dissection (PLND) varies depending on the disease and practice patterns. AIMS... 
Database | Vattikuti Collective Quality Initiative database | pelvic lymph node dissection | robot-Assisted prostatectomy | practice patterns | CANCER | robot-assisted prostatectomy | LYMPHADENECTOMY | ONCOLOGY | MEN | DISEASE | COHORT | OUTCOMES | PSA
Journal Article